Review of radiotherapy and hyperthermia in primary cervical cancer

International Journal of Hyperthermia

Volumn 28, Issue 6, 2012, Pages 543-548

  Franckena, Martine ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervix cancer; Clinical trials; Deep

Indexed keywords

CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; HYPERTHERMIC THERAPY; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; UTERINE CERVICAL NEOPLASMS;

EID: 84865325156     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2012.670835     Document Type: Review

References (33)

1. Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005;4:CD002225.
2. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, William CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001;358:781-786. (Pubitemid 32868726)
3. Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. Clin Oncol (R Coll Radiol) 2002;14:203-212.
4. Vale C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and metaanalysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.
5. Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: A report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1989;16:551-558. (Pubitemid 19079691)
6. Franckena M, van der Zee J. Use of combined radiation and hyperthermia for gynecological cancer. Curr Opin Obstet Gynecol 2010;22:9-14.
7. Canters RA, Franckena M, van der Zee J, Van Rhoon GC. Complaint-adaptive power density optimization as a tool for HTP-guided steering in deep hyperthermia treatment of pelvic tumors. Phys Med Biol 2008;53:6799-6820.
8. Franckena M, Canters R, Termorshuizen F, Van Der Zee J, Van Rhoon G. Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia 2010;26:145-157.
9. Franckena M, Fatehi D, de Bruijne M, Canters RA, van Norden Y, Mens JW, et al. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009;45:1969-1978.
10. Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011;187:605-610.
11. Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: Correlation with response and direct thermometry. Cancer 2006;107:1373-1382. (Pubitemid 44452788)
12. Gellermann J, Wlodarczyk W, Ganter H, Nadobny J, Fahling H, Seebass M, et al. A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: Validation in a heterogeneous phantom. Int J Radiat Oncol Biol Phys 2005;61:267-277. (Pubitemid 40039131)
13. Kampinga HH. Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field. Int J Hyperthermia 2006;22:191-196. (Pubitemid 43878678)
14. Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989;16:535-549. (Pubitemid 19079690)
15. Horsman MR, Overgaard J. Hyperthermia: A potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007;19:418-426. (Pubitemid 46995618)
16. Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002;18:563-575. (Pubitemid 35469188)
17. Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008;24:41-56. (Pubitemid 351167618)
18. Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADPribose) polymerase-1 inhibition. Proc Natl Acad Sci USA 2011;108:9851-9856.
19. Datta N, Bose A, Kapoor HK. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): A controlled clinical study. Indian Med Gaz 1987;121:68-71.
20. Chen H, Jun-Jie F, Wei L. A randomized trial of hyperthermoradiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 1997;24:249-251. (Pubitemid 27231507)
21. Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001;17:97-105. (Pubitemid 32185837)
22. Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 2005;61:145-153. (Pubitemid 40039116)
23. Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-1125. (Pubitemid 30172932)
24. Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: An update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 2008;70:1176-1182. (Pubitemid 351296102)
25. Sharma S, Patel FD, Sandhu AP, Gupta BD, Yadav NS. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/ Hyperthermia Oncol 1989;5:151-159.
26. Jones EL, Prosnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, et al. In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153).
27. Int J Radiat Oncol Biol Phys 2005;63:644.
28. Van der Zee J, van Rhoon GC, Wust P. In regard to Dr. Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145- 153)
29. Int J Radiat Oncol Biol Phys 2005;62:940-941.
30. Lutgens LCHW, van der Zee J, Pijls-Johannesma M, de Haas- Kock DFM, Buijsen J, Mastrigt GAPGV, et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix cancer. Cochrane Database Syst Rev 2010;3:CD006377.
31. Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005;104:763-770. (Pubitemid 41113675)
32. Potter R, Dimopoulos J, Georg P, Lang S, Waldhausl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148-155. (Pubitemid 46783926)
33. Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002;12:260-271. (Pubitemid 34755932)